Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Coherus Prepares To Wave Goodbye To Udenyca – And 30% Of Its Staff
Final Annual Results Before Transfer Of Pegfilgrastim Franchise
Mar 13 2025
•
By
Dave Wallace
Coherus is losing 30% of its 225 employees
(Shutterstock)
More from Strategy
More from Products